<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Monday Biotech Deal Review: February 8, 2010</title>
	<atom:link href="http://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/feed/" rel="self" type="application/rss+xml" />
	<link>http://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/</link>
	<description>Biotechnology, Health and Business in Canada, the United States and Worldwide</description>
	<lastBuildDate>Sat, 10 Dec 2011 04:09:15 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Monday Biotech Deal Review: March 22, 2010 &#171; The Cross-Border Biotech Blog</title>
		<link>http://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/comment-page-1/#comment-1475</link>
		<dc:creator><![CDATA[Monday Biotech Deal Review: March 22, 2010 &#171; The Cross-Border Biotech Blog]]></dc:creator>
		<pubDate>Mon, 22 Mar 2010 11:02:42 +0000</pubDate>
		<guid isPermaLink="false">http://crossborderbiotech.ca/?p=4084#comment-1475</guid>
		<description><![CDATA[[...] targeted fusion proteins for the treatment of prostate disease and other cancers, closed its previously announced brokered private placement of units for gross proceeds of approximately $5.1 million. Dundee [...]]]></description>
		<content:encoded><![CDATA[<p>[...] targeted fusion proteins for the treatment of prostate disease and other cancers, closed its previously announced brokered private placement of units for gross proceeds of approximately $5.1 million. Dundee [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Monday Biotech Deal Review: March 1, 2010 &#171; The Cross-Border Biotech Blog</title>
		<link>http://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/comment-page-1/#comment-1427</link>
		<dc:creator><![CDATA[Monday Biotech Deal Review: March 1, 2010 &#171; The Cross-Border Biotech Blog]]></dc:creator>
		<pubDate>Mon, 01 Mar 2010 12:04:47 +0000</pubDate>
		<guid isPermaLink="false">http://crossborderbiotech.ca/?p=4084#comment-1427</guid>
		<description><![CDATA[[...] Inc. (TSX: PRX) revised the terms of its previously announced private placement (covered here).  Instead of intending to raise $8,000,000 by issuing units priced at $0.55 per unit, the company [...]]]></description>
		<content:encoded><![CDATA[<p>[...] Inc. (TSX: PRX) revised the terms of its previously announced private placement (covered here).  Instead of intending to raise $8,000,000 by issuing units priced at $0.55 per unit, the company [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tweets that mention Monday Biotech Deal Review: February 8, 2010 « The Cross-Border Biotech Blog -- Topsy.com</title>
		<link>http://crossborderbiotech.ca/2010/02/08/monday-biotech-deal-review-february-8-2010/comment-page-1/#comment-1365</link>
		<dc:creator><![CDATA[Tweets that mention Monday Biotech Deal Review: February 8, 2010 « The Cross-Border Biotech Blog -- Topsy.com]]></dc:creator>
		<pubDate>Tue, 09 Feb 2010 01:39:38 +0000</pubDate>
		<guid isPermaLink="false">http://crossborderbiotech.ca/?p=4084#comment-1365</guid>
		<description><![CDATA[[...] This post was mentioned on Twitter by Ogilvy Renault and Jeremy Grushcow, Adam Currington. Adam Currington said: Monday Biotech Deal Review: February 8, 2010 « The Cross-Border ...: The material and information provided on this... http://bit.ly/b4TShA [...]]]></description>
		<content:encoded><![CDATA[<p>[...] This post was mentioned on Twitter by Ogilvy Renault and Jeremy Grushcow, Adam Currington. Adam Currington said: Monday Biotech Deal Review: February 8, 2010 « The Cross-Border &#8230;: The material and information provided on this&#8230; <a href="http://bit.ly/b4TShA" rel="nofollow">http://bit.ly/b4TShA</a> [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

